Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A

Acta Haematologica

Volumn 127, Issue 1, 2011, Pages 10-15

  Kobayashi, Tsutomu ^a   Kuroda, Junya ^a   Uchiyama, Hitoji ^a   Matsumoto, Yosuke ^a   Horiike, Shigeo ^a   Taniwaki, Masafumi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Angioimmunoblastic T cell lymphoma; Chemotherapy; Cyclosporin A

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; PREDNISOLONE; SOLUBLE INTERLEUKIN 2 RECEPTOR; VINCRISTINE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANASARCA; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RESISTANCE; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; DENDRITIC CELL; DRUG EFFICACY; DRUG MEGADOSE; EOSINOPHIL; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOBLAST; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAINTENANCE THERAPY; PLASMA CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASH; SKIN BIOPSY; T CELL LYMPHOMA; TREATMENT OUTCOME; TUMOR REGRESSION; VENULE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOSPORINE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, T-CELL;

EID: 80053461868     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000330950     Document Type: Article

References (24)

1. Iannitto E, Ferreri A, Minardi V, Tripodo C, Kreipe H: Angioimmunoblastic T-cell lymphoma. Crit Rev Oncol Hematol 2008; 68: 264-271.
2. Reiser M, Josting A, Soltani M, Staib P, Salzberger B, Diehl V, Engert A: T-cell non- Hodgkin's lymphoma in adults: Clinicopathological characteristics, response to treatment and prognostic factors. Leuk Lymphoma 2002; 43: 805-811.
3. Kyriakou C, Canals C, Goldstone A, Caballero D, Metzner B, Kobbe G, Kolb HJ, Kienast J, Reimer P, Finke J, Oberg G, Hunter A, Theorin N, Sureda A, Schmitz N: High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: Complete remission at transplantation is the major determinant of outcome - Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008; 26: 218-224.
4. Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M, Narni F, Patriarca F, Boccadoro M, Benedetti F, Rambaldi A, Gianni AM, Tarella C: Graft-versus-lymphoma effect in relapsed peripheral T-cell non- Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004; 22: 2172-2176.
5. Kyriakou C, Canals C, Finke J, Kobbe G, Harousseau JL, Kolb HJ, Novitzky N, Goldstone AH, Sureda A, Schmitz N: Allogeneic stem cell transplantation is able to induce longterm remissions in angioimmunoblastic Tcell lymphoma: A retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol 2009; 27: 3951-3958.
6. Siegert W, Nerl C, Meuthen I, Zahn T, Brack N, Lennert K, Huhn D: Recombinant human interferon- α in the treatment of angioimmunoblastic lymphadenopathy: Results in 12 patients. Leukemia 1991; 5: 892-895.
7. Strupp C, Aivado M, Germing U, Gattermann N, Haas R: Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: Two case reports. Leuk Lymphoma 2002; 43: 133-137.
8. Ramasamy K, Lim Z, Pagliuca A, Salisbury JR, Mufti GJ, Devereux S: Successful treatment of refractory angioimmunoblastic Tcell lymphoma with thalidomide and dexamethasone. Haematologica 2006; 91:e117-e118.
9. Gallamini A, Zaja F, Patti C, Billio A, Specchia MR, Tucci A, Levis A, Manna A, Se condo V, Rigacci L, Pinto A, Iannitto E, Zoli V, Torchio P, Pileri S, Tarella C: Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: Results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood 2007; 110: 2316-2323.
10. Advani R, Horwitz S, Zelenetz A, Horning SJ: Angioimmunoblastic T cell lymphoma: Treatment experience with cyclosporine. Leuk Lymphoma 2007; 48: 521-525.
11. Murayama T, Imoto S, Takahashi T, Ito T, Matozaki S, Nakagawa T: Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A. Cancer 1992; 69: 2567-2570.
12. Takemori N, Kodaira J, Toyoshima N, Sato T, Sakurai H, Akakura N, Kimura S, Katagiri M: Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A. Leuk Lymphoma 1999; 35: 389-395.
13. Takemori N, Kodaira J, Sato T, Sakurai H, Akakura N, Kimura S, Katagiri M: Successful treatment of IBL-like T-cell lymphoma with cyclosporin A: Two case reports with special reference to serum cytokine levels. Hum Cell 2000; 13: 35-42.
14. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Go JH, Suzumiya J, Kim DS: Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol 1998; 22: 643-655.
15. Rojnuckarin P, Nakorn TN, Assanasen T, Wannakrairot P, Intragumtornchai T: Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma 2007; 48: 560-563.
16. Tsukamoto Y, Katsunobu Y, Omura Y, Maeda I, Hirai M, Teshima H, Konishi Y, Inoue T, Sato T. Subcutaneous panniculitis-like Tcell lymphoma: Successful initial treatment with prednisolone and cyclosporine A. Intern Med 2006; 45: 21-24.
17. Al Zolibani AA, Al Fawzan S, Al Robaee AA, Qureshi MG, Al Nosian H: Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporine A. Skinmed 2006; 5: 195-197.
18. Mizutani S, Kuroda J, Shimura Y, Kobayashi T, Tsutsumi Y, Yamashita M, Yamamoto M, Ohshiro M, Sasaki N, Kiyota M, Nakayama R, Uchiyama H, Matsumoto Y, Horiike S, Nakamura S, Taniwaki M: Cyclosporine A for chemotherapy-resistant subcutaneous panniculitis-like T cell lymphoma with hemophagocytic syndrome. Acta Haematol 2011; 126: 8-12.
19. Cooper DL, Braverman IM, Sarris AH, Durivage HJ, Saidman BH, Davis CA, Hait WN: Cyclosporine treatment of refractory Tcell lymphomas. Cancer 1993; 71: 2335-2341.
20. Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A: Angioimmunoblastic T-cell lymphoma: A neoplasm of germinal-center T-helper cells? Blood 2005; 106: 1501-1502.
21. Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A: Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006; 19: 1101-1107.
22. Dunleavy K, Wilson WH: Angioimmunoblastic T-cell lymphoma: Immune modulation as a therapeutic strategy. Leuk Lymphoma 2007; 48: 449-451.
23. Uno M, Tsuchiyama J, Moriwaki A, Noguchi T, Mizoguchi K, Ogino T, Yoshino T, Okada S, Harada M: In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma- derived cell lines, NK-YS, by etoposide and cyclosporine A. Br J Haematol 2001; 113: 1009-1014.
24. Medyouf H, Alcalde H, Berthier C, Guillemin MC, dos Santos NR, Janin A, Decaudin D, de Thé H, Ghysdael J: Targeting calcineurin activation as a therapeutic strategy for Tcell acute lymphoblastic leukemia. Nat Med 2007; 13: 736-741.